Largest Canadian Cannabis LP Performances: An Update

Image source

The 5 largest licensed producers (LPs), as tracked in the munKNEE Canadian Cannabis LPs Index, are ranked below in descending order as to their stock performances since the beginning of March (MTD) and year-to-date (YTD), their likelihood of Financial Distress within the next 2 years (according to data from macroaxis.com), their average 12-month Price Targets (from stockanalysis.com), and the extent of Short Interest and Insider Ownership (from SeekingAlpha.com).

  1. Cronos (CRON): DOWN 1.0% MTD; DOWN 22.6% YTD
    • 18 analysts:
      • have an average 12-month price target of $3.42
        • representing a 75% increase from the March 17th price of $1.95 and
      • have a consensus BUY rating.
    • In addition, CRON has:
      • a 2% chance of Financial Distress within 2 years,
      • a Short Interest (the number of shorted shares divided by the number of shares outstanding) of only 3.7%; and
      • an Insider Ownership (directors and senior officers or other beneficial holders with 10% or more of the common shares) of only 5.1%.
  2. Tilray (TLRY): DOWN 7.8% MTD; DOWN just 2.2% YTD
    • 22 analysts:
      • have an average 12-month price target of $4.35
        • representing a 67% increase from the March 17th price of $2.61 and
      • have a consensus BUY rating.
    • In addition, TLRY has:
      • a 68% chance of Financial Distress within 2 years,
      • a Short Interest of only 7%; and
      • an Insider Ownership of only 1.3%.
  3. Aurora (ACB): DOWN 13.1% MTD; DOWN 18.0% YTD
    • 14 analysts:
      • have an average 12-month price target of $1.32
        • representing a 81% increase from the March 17th price of $0.73 and
      • have a consensus HOLD rating.
    • In addition, ACB has:
      • a 78% chance of Financial Distress within 2 years,
      • a Short Interest of only 8.7%; and
      • an Insider Ownership of only 0.12%.
  4. OrganiGram (OGI): DOWN 20.3% MTD; DOWN 19.2% YTD
    • 15 analysts:
      • have an average 12-month price target of $1.50 
        • representing a 138% increase from the March 17th price of $0.63 and
      • have a consensus BUY rating.
    • In addition, OGI has:
      • a 49% chance of Financial Distress within 2 years,
      • a Short Interest of only 2.1%; and
      • an Insider Ownership of only 0.09%.
  5. Canopy Growth (CGC): DOWN 13.4 MTD; DOWN 11.9% YTD
    • 23 analysts:
      • have an average 12-month price target of $2.22 representing
        • representing a 11% increase from the March 17th price of $2.00 and
      • have a consensus SELL rating.
    • In addition, CGC has:
      • a 53% chance of Financial Distress within 2 years,
      • a Short Interest of 16.1%; and
      • an Insider Ownership of only 0.09%.

On average, the 12-month forecasts mentioned above represent an increase of 65.0% from the current average price of these 5 Canadian cannabis LPs and the recent decline in their average stock prices has caused the average 12-month percentage price target to go up from 62.5% just one week ago.


More By This Author:

An Update On The Performance Of The 7 Largest Psychedelic Stocks
The "Multi-Bagger" Portfolio: An Update
The "Rags-To-Riches" Portfolio: An Update

Disclosure: None

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.